Qualitative Analysis of Patient Characters, Interviews on the Burden of Neuronopathic Gaucher Disease in Japan

Author(s)

Noto S1, Ono M2, Koto Y3, Narita A4, Hamada AL2, Sakai N5
1Niigata University of Health and Welfare, Niigata, Japan, 2Takeda Pharmaceutical Co., Ltd, Chuo-ku, 13, Japan, 3Osaka Aoyama University, Osaka, Japan, 4Tottori University, Tottori, Japan, 5Osaka University, Osaka, Japan

Presentation Documents

OBJECTIVES: Gaucher disease (GD) is a rare, autosomal recessive lysosomal storage disorder that adversely affects life expectancy and health-related quality of life (HRQOL). Although HRQOL questionnaires were reported for type 1 GD, they are not suitable for patients with the neuronopathic types 2 and 3 GD that develop during early childhood or adolescence. We report the development of a language-validated HRQOL questionnaire specifically for patients with neuronopathic types 2 and 3 GD in Japan, which is the first step toward HRQOL questionnaire for all types of GD in the future.

METHODS: Semi-structured interviews were conducted with patients and/or their caregivers (for patients <16 years old) who were recruited from the Association of Gaucher Disease Patients in Japan. Qualitative analysis of interview transcripts was used to identify major themes and key topics within those themes. Hierarchical cluster analysis and co-occurrence network analysis were performed to map relationships between commonly occurring words.

RESULTS: Eight patients (each four with type 2 and type 3 GD) recruited in the interview. Three main themes emerged from qualitative analysis: treatment status, patient burden, and social support systems. Key topics and words within each theme were identified. Commonly used words and the relationships between words identified through the hierarchical cluster and co-occurrence network analyses supported these themes and topics.

CONCLUSIONS: The themes and topics identified in this analysis were specific to patients with types 2 and 3 GD and will be used to develop a HRQOL questionnaire specifically for patients with all GD types.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

PCR10

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

SDC: Rare & Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×